| 07.08 13:32 | dpa-AFX: Zimmer Biomet Holdings Q2 24 Earnings Conference Call At 8:30 AM ET |
| 07.08 13:09 | dpa-AFX: ROUNDUP: Zimmer Biomet Trims FY24 Revenue Growth Outlook; To Acquire OrthoGrid Systems |
| 07.08 12:41 | dpa-AFX: *ZIMMER BIOMET Q2 NET EARNINGS OF ZIMMER BIOMET $242.8 MLN VS $209.6 MLN LAST YEAR |
| 07.08 12:40 | dpa-AFX: Zimmer Biomet Holdings Inc. Q2 Profit Increases, Beats Estimates |
| 07.08 12:40 | dpa-AFX: *ZIMMER BIOMET UPDATES 2024 REPORTED REVENUE GUIDANCE; NOW SEES GROWTH IN RANGE OF 4.0% - 5.0% |
| 07.08 12:39 | dpa-AFX: *ZIMMER BIOMET REAFFIRMS 2024 CONSTANT CURRENCY REVENUE GROWTH AND ADJ EPS VIEW |
| 07.08 12:39 | dpa-AFX: *ZIMMER BIOMET Q2 NET SALES $1.942 BLN, UP 3.9% AND 5.6% ON A CONSTANT CURRENCY BASIS |
| 07.08 12:32 | dpa-AFX: *ZIMMER BIOMET Q2 EPS $1.18; ADJ EPS $2.01; AGREES TO ACQUIRE ORTHOGRID SYSTEMS |
| 20.06 13:32 | dpa-AFX: *ZIMMER BIOMET APPOINTS DEVDATT KURDIKAR TO BOARD |
| 11.06 13:47 | dpa-AFX: Zimmer Biomet In Distribution Deal With THINK Surgical For TMINI Miniature Handheld Robotic System |
| 11.06 13:33 | dpa-AFX: *ZIMMER BIOMET ENTERS DISTRIBUTION AGREEMENT WITH THINK SURGICAL TO OFFER TMINI MINIATURE HANDHELD ROBOTIC SYSTEM |
| 30.05 12:36 | dpa-AFX: *GOLDMAN STARTS ZIMMER BIOMET WITH 'NEUTRAL' - PRICE TARGET 129 USD |
| 30.05 12:36 | dpa-AFX: *GOLDMAN STARTET ZIMMER BIOMET MIT 'NEUTRAL' - ZIEL 129 USD |
| 30.05 04:53 | dpa-AFX: Zimmer Biomet To Repurchase Up To $2 Bln Of Common Stock |
| 29.05 18:03 | dpa-AFX: Zimmer Biomet Holdings 2024 Investor Day Webcast At 1:00 PM ET |
| 13.05 13:09 | dpa-AFX: *ZIMMER BIOMET ANNOUNCES Q2 CASH DIVIDEND OF $0.24/SHR; RECORD JUNE 26/PAYABLE ON OR ABOUT JULY 31 |
| 13.05 13:07 | dpa-AFX: *ZIMMER BIOMET HOLDINGS INC. (ZBH) DECLARES $ 0.24 DIVIDEND FOR Q2 24, RECORD DATE 6/26/2024 |
| 02.05 12:47 | dpa-AFX: Zimmer Biomet Holdings Inc. Q1 Profit Decreases, but beats estimates |
| 02.05 12:41 | dpa-AFX: *ZIMMER BIOMET CONTINUES TO EXPECT FY24 REPORTED REVENUE GROWTH OF 4.5% - 5.5% |
| 02.05 12:41 | dpa-AFX: *ZIMMER BIOMET CONTINUES TO EXPECT FY24 ADJ. EPS OF $8.00 - $8.15 |
|
|
